AVTE Stock, Aerovate Therapeutics Inc. Information
Stock Information
Get AVTE Alerts
News, Short Squeeze, Breakout and More Instantly...
About Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.